Transrectal ultrasound guided (TRUS) biopsy has been the gold standard for prostate cancer diagnosis, but carries a significant risk of urinary tract infection, sometimes requiring hospital admission ...

Lee Horstein remembers the phone call from Dr. Michael Kaplan. "It was after my second prostate biopsy from him about four years ago," the 69-year-old retired businessman said as he sat in an ...

We sought to determine whether formalin disinfection of prostate biopsy needles between cores reduces post-biopsy urinary tract infections (UTIs). We reviewed a single-surgeon experience of ...

LAS VEGAS (CN) - A federal jury on Thursday convicted Las Vegas urologist Michael Stanley Kaplan of reusing single-use needle guides while treating patients for prostate conditions. Kaplan, 59, ...

Greater diagnostic accuracy in detecting significant prostate cancer has been reported following a 4-year clinical evaluation at Castle Hill Hospital, part of Hull University Teaching Hospitals NHS ...

A revolutionary prostate biopsy approach uses fewer needles and is more accurate for diagnosing prostate cancer. It is done during a real time MRI (magnetic resonance imaging) scan that clearly shows ...

When Dr. Lawrence Newman learned that the FDA and the Nevada State Medical Board sanctioned Dr. Michael Kaplan in early March for reusing single-use medical devices during prostate biopsy procedures, ...

September is Prostate Cancer Awareness Month. Prostate cancer affects one in six men in the U.S. Urologists recommend men between the ages of 50 and 75 get a prostate screening, which includes a ...

Prostate cancer is the most commonly diagnosed cancer in men in the UK. It mainly affects people over 50 and the risk is higher for people of African family background and people with a family history ...

Performance of MRI-TRUS-guided fusion biopsy to detect progression on active surveillance for low- and intermediate-risk prostate cancer. A first catch, non-DRE urine exosome gene signature to predict ...

San Diego, Calif. - Prostate cancer is the leading cancer among men, second only to skin cancer. With surgical removal at the frontline of defense, oncologists are considering prostate-specific ...